Detailed price information for Tenaya Therapeutics Inc (TNYA-Q) from The Globe and Mail including charting and trades.

Gladstone Institutes hopes to buy 103,400 square feet of life sciences research offices near its hub in San Francisco’s ...

The company forecast annual revenue of $4.28 billion to $4.4 billion for 2025, the midpoint of which is below analysts' ...

Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...

After winning a breakthrough therapy designation for its Hunter syndrome enzyme replacement therapy, Denali Therapeutics is ...

K18 Biomimetic Hairscience, the cutting-edge biotech haircare brand, is proud to announce its upcoming launch at Cosmo Prof today. This marks the brand's continued expansion to support professional ...

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...

Belite Bio is a biotech firm specializing in innovative therapies for retinal degenerative eye diseases with high unmet needs ...

Learn more about whether Arrowhead Pharmaceuticals, Inc. or Veracyte, Inc. is a better investment based on AAII's A+ Investor ...

Calidi Biotherapeutics, Inc., a biotechnology company specializing in biological products, has increased its stock offering capacity under its existing Sales Agreement with Ladenburg Thalmann & Co.

IR700 is being investigated in several other therapeutic modalities targeting diseases such as ocular melanoma and bladder cancer Rakuten Medical strengthens its technology platform and business ...